生物制品板块11月21日跌3.1%，金迪克领跌，主力资金净流出11.25亿元

Market Overview - The biopharmaceutical sector experienced a decline of 3.1% on November 21, with Jindike leading the drop [1] - The Shanghai Composite Index closed at 3834.89, down 2.45%, while the Shenzhen Component Index closed at 12538.07, down 3.41% [1] Individual Stock Performance - Notable stock performances included: - Teabo Bio (688278) closed at 78.36, up 0.72% with a trading volume of 19,100 and a turnover of 150 million [1] - Wanze Co. (000534) closed at 20.26, up 0.55% with a trading volume of 226,200 and a turnover of 464 million [1] - Jindike (688670) closed at 20.87, down 10.47% with a trading volume of 69,100 and a turnover of 149 million [2] - Sanyuan Gene (920344) closed at 25.60, down 7.15% with a trading volume of 23,100 and a turnover of 60.83 million [2] Capital Flow Analysis - The biopharmaceutical sector saw a net outflow of 1.125 billion from institutional investors, while retail investors had a net inflow of 902 million [2][3] - The capital flow for individual stocks indicated varying trends, with some stocks experiencing significant net outflows from institutional investors [3]